Cargando…

Identification of HER2-positive breast carcinomas as a particular subset with peculiar clinical behaviours

Detalles Bibliográficos
Autores principales:	Casalini, P, Ménard, S, Balsari, A, Tagliabue, E, Campiglio, M, Bufalino, R, Cascinelli, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300523/ http://dx.doi.org/10.1186/bcr340

Ejemplares similares

Rescue of HER-2-positive breast carcinoma cells from dormancy by growth factors produced during wound healing
por: Agresti, R, et al.
Publicado: (2001)

Role of hormonal risk factors in HER2-positive breast carcinomas
por: Balsari, A, et al.
Publicado: (2003)

Restored expression of Fhit protein in Fhit-minus breast cancer cells
por: Campiglio, M, et al.
Publicado: (2001)

“Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas
por: Tagliabue, Elda, et al.
Publicado: (2014)

Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.
por: Tagliabue, E., et al.
Publicado: (1996)

Analysis of Fhit expression in stages of breast cancer progression
por: Campiglio, M, et al.
Publicado: (2000)

EHMTI-0009. A particular case of cluster headache
por: Tertan, D, et al.
Publicado: (2014)

Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration
por: Triulzi, Tiziana, et al.
Publicado: (2015)

Is `brain swelling' a clinical particular kind of severe brain injury?
por: Bertault, R, et al.
Publicado: (1997)

Basic and clinical immunology – 3034. Peculiarities of parameters immune system in juvenile rheumatoid arthritis
por: Musakhodjaeva, Diloram Abdullaevna, et al.
Publicado: (2013)

Prognosis based on primary breast carcinoma instead of pathological nodal status.
por: Ménard, S., et al.
Publicado: (1994)

Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
por: Cedeño, Heidy, et al.
Publicado: (2007)

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
por: Campiglio, M., et al.
Publicado: (2013)

Anti-HER2 mAb plus calicheamicin immunoconjugate linked on liposomal vinorelbine induces ADCC and apoptosis in HER2-positive high grade DCIS
por: Giannos, J, et al.
Publicado: (2000)

Dendritic cell subsets in rheumatoid arthritis
por: Summers, K, et al.
Publicado: (2001)

Contribution of T Cell Subsets to Joint Degradation
por: Miossec, Pierre
Publicado: (2000)

Intratumor lactate levels reflect HER2 addiction status in HER2‐positive breast cancer
por: Castagnoli, Lorenzo, et al.
Publicado: (2018)

Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress
por: Triulzi, Tiziana, et al.
Publicado: (2013)

RCAN1C is differentially expressed in T helper cell subsets
por: Sieber, M, et al.
Publicado: (2009)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors
por: Lucci, Maria Antonietta, et al.
Publicado: (2010)

Patterns of cytokines and lymphocyte subsets in patients with breast and prostate cancer treated with a standardized mistletoe extract preparation
por: Wetzel, D, et al.
Publicado: (2001)

Effects of boundary conditions on foot behaviour in the standing position in 3D finite element foot model
por: Johnson, Shane, et al.
Publicado: (2014)

Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis
por: De Rycke, L, et al.
Publicado: (2004)

Decreased subsets of T lymphocytes CD8 in patients with IgE food allergy
por: Tenorio, Isaac Azevedo, et al.
Publicado: (2015)

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer
por: Castagnoli, L, et al.
Publicado: (2017)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

Characterization of BDCA1 and BDCA4 dendritic cell subsets in rheumatoid arthritis patients
por: Lebre, MC, et al.
Publicado: (2004)

Effect of IL-18 on synovial cell subsets and its regulation by IL-18BP
por: Kawashima, M, et al.
Publicado: (2002)

Characterization of leukemia-specific NK cell subsets against acute lymphoblastic leukemia in children
por: Babor, Florian, et al.
Publicado: (2014)

Treatment of pulmonary hypertension
por: Tagliabue, Paolo, et al.
Publicado: (2014)

Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment
por: Rybinska, Ilona, et al.
Publicado: (2020)

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
por: Bar, Julia K, et al.
Publicado: (2012)

Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinoma.
por: Facheris, P., et al.
Publicado: (1992)

Advancing the Care of Women With HER2-Positive Metastatic Breast Cancer
por: Beasley, Marcie, et al.
Publicado: (2023)

A subset of memory effector T cells in peripheral blood defined by differential expression of the TCR-ζ chain
por: Zhang, Z, et al.
Publicado: (2003)

Assessment of the agreement between cardiac output measured by thermal filament continuous thermodilution (CCO) and noninvasive partial CO(2) rebreathing (NICO) with particular reference to ETCO(2) levels
por: Crespo, AS, et al.
Publicado: (2002)

Haemoglobin behaviour in critical patients
por: Machado, AS, et al.
Publicado: (2003)

Asthma in Canada: perceptions and behaviours
por: Kim, Harold, et al.
Publicado: (2011)

Comparative Study between Quantitative Digital Image Analysis and Fluorescence In Situ Hybridization of Breast Cancer Equivocal HER2 2+ Cases
por: Ayad, E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_isutam3ei6m9r13ts39mr02onf